Evidence map›Paper›PMID 39687930›Full record

ArticleResearch and practice in thrombosis and haemostasis2024

Risk factors for neurologic sequelae in children and adolescents with hemophilia after intracranial hemorrhage.

Melike Sezgin Evim, Ayşegül Ünüvar, Canan Albayrak, Emine Zengin, Ebru Yılmaz, Zühre Kaya, Nihal Karadaş, Mehtap Ertekin, Hülya Üzel, Gül Nihal Özdemir and 13 more

Abstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Melike Sezgin EvimDivision of Pediatric Hematology, Uludag University Faculty of Medicine, Bursa, Turkey.
Ayşegül ÜnüvarDivision of Pediatric Hematology and Oncology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Turkey.
Canan AlbayrakDivision of Pediatric Hematology and Oncology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey.
Emine ZenginDivision of Pediatric Hematology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey.
Ebru YılmazDivision of Pediatric Hematology and Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey.
Zühre KayaDivision of Pediatric Hematology, Gazi University Faculty of Medicine, Ankara, Turkey.
Nihal KaradaşDivision of Pediatric Hematology, Ege University Faculty of Medicine, İzmir, Turkey.
Mehtap ErtekinDivision of Pediatric Hematology, Bakırçay University, Çiğli Training and Research Hospital, İzmir, Turkey.
Hülya ÜzelDivision of Pediatric Hematology and Oncology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.
Gül Nihal ÖzdemirDivision of Pediatric Hematology, İstinye University Faculty of Medicine, İstanbul, Turkey.
Davut AlbayrakDivision of Pediatric Hematology and Oncology, Medicalpark Samsun Hospital, Samsun, Turkey.
Funda Tayfun KüpesizDivision of Pediatric Hematology and Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Ayşenur BahadırDivision of Pediatric Hematology and Oncology, Karadeniz Technical University, Faculty of Medicine, Trabzon, Turkey.
Hüseyin TokgözDivision of Pediatric Hematology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey.
Kamuran KaramanDivision of Pediatric Hematology, Van 100.yıl University Faculty of Medicine, Van, Turkey.
Barış YılmazDivision of Pediatric Hematology and Oncology, Marmara University Faculty of Medicine, İstanbul, Turkey.
Sinan AkbayramDivision of Pediatric Hematology and Oncology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey.
Burçak Tatlı GüneşDivision of Pediatric Hematology, İzmir Tepecik Training and Research Hospital, İzmir, Turkey.
Burcu Belen ApakDivision of Pediatric Hematology and Oncology, Başkent University Faculty of Medicine, Ankara, Turkey.
Can AcıpayamDivision of Pediatric Hematology and Oncology, Sütçü İmam University Faculty of Medicine, Kahramanmaraş, Turkey.
Yusuf Ziya AralDivision of Pediatric Hematology, Adnan Menderes University Faculty of Medicine, Aydın, Turkey.
Serap KaramanDivision of Pediatric Hematology and Oncology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Turkey.
Hale ÖrenDivision of Pediatric Hematology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intracranial hemorrhage (ICH) is reportedly rare but has high morbidity and mortality risk in persons with hemophilia. Although the risk factors that facilitate bleeding are known, the factors affecting the sequelae are not well known. Objectives: We planned to investigate the risk factors for neurologic sequelae in children and adolescents with hemophilia suffering from ICH. Methods: An invitation was sent to pediatric hematology centers via email. Clinical and laboratory findings, neurologic sequelae, and recurrence of bleeding in persons with hemophilia who developed ICH were questioned. Results: Eighty-six patients from 21 centers were evaluated. All patients were less than 18 years of age at the time of ICH. Thirteen patients had ICH in the neonatal period, while 40 patients had a known diagnosis of hemophilia before ICH, and 33 patients were undiagnosed before ICH. Five patients died, 2 of whom died in the neonatal period. The rate of neurologic sequelae was 25 of 81 (30%). The most common neurologic sequela was epilepsy ( Conclusion: ICH in the neonatal period and cerebral shift were the two main risk factors for the development of neurologic sequelae. Neonatal departments must be alert to the signs of bleeding. It is important for healthcare professionals to overcome the barriers to primary prophylaxis and to take trauma-related precautions.

Indexed as

adolescentschildrenhemophiliaintracranial hemorrhageoutcome

Identifiers

PMID39687930
PMCPMC11647224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.